Literature DB >> 11751119

Carrier-mediated partitioning of artemisinin into Plasmodium falciparum-infected erythrocytes.

Nehal Vyas1, Bonnie A Avery, Mitchell A Avery, Christy M Wyandt.   

Abstract

The purpose of the present study was to characterize the partitioning of artemisinin into both uninfected and Plasmodium falciparum-infected red blood cells (RBCs). The partitioning of [(14)C](+)-artemisinin into RBCs was studied at four different hematocrit levels and eight time periods. At the optimum time of 2 h, the partitioning process was investigated with eight different drug concentrations ranging from 0.88 to 3.52 microM at 37 and 4 degrees C. The effect of the presence of unlabeled artemisinin on the partitioning of the same concentration of [(14)C]artemisinin was studied. About 35 to 40% of the drug was seen to partition into uninfected RBCs at a hematocrit of 33%, irrespective of the incubation period or the drug concentration used. In contrast, infected RBCs showed an increase in partitioning of the drug with time until saturation was achieved at 1 h. While the partitioning of artemisinin into parasitized RBCs at 37 degrees C was found to be significantly higher than that in nonparasitized RBCs, at 4 degrees C both parasitized and nonparasitized RBCs showed identical partitioning of the drug. The partitioning of [(14)C]artemisinin into parasitized RBCs was completely inhibited in the presence of the same concentration of unlabeled artemisinin. However, no such effect was observed in nonparasitized cells, and no evidence suggesting that binding of the drug in parasitized RBCs is reversible was found. The partitioning of artemisinin into parasitized RBCs was found to be rapid, saturable, temperature dependent, irreversible, and subject to competitive inhibition with unlabeled artemisinin. The results obtained suggest the involvement of carrier mediation in the partitioning of artemisinin across the parasitized RBC membrane. In contrast, simple passive diffusion of artemisinin was seen in nonparasitized RBCs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751119      PMCID: PMC127011          DOI: 10.1128/AAC.46.1.105-109.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Antimalarial agents: mechanism of chloroquine resistance.

Authors:  D J Krogstad; P H Schlesinger; B L Herwaldt
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

Review 2.  Altered membrane transport of malaria-infected erythrocytes: a possible pharmacologic target.

Authors:  Z L Cabantchik
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

Review 3.  Biophysical analysis of novel transport pathways induced in red blood cell membranes.

Authors:  H Ginsburg; W D Stein
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

4.  Artemisinin and its derivatives are transported by a vacuolar-network of Plasmodium falciparum and their anti-malarial activities are additive with toxic sphingolipid analogues that block the network.

Authors:  T Akompong; J VanWye; N Ghori; K Haldar
Journal:  Mol Biochem Parasitol       Date:  1999-06-25       Impact factor: 1.759

5.  A study of the uptake of chloroquine in malaria-infected erythrocytes. High and low affinity uptake and the influence of glucose and its analogues.

Authors:  C O Diribe; D C Warhurst
Journal:  Biochem Pharmacol       Date:  1985-09-01       Impact factor: 5.858

6.  Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro.

Authors:  H M Gu; D C Warhurst; W Peters
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

7.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

8.  Arteether, a new antimalarial drug: synthesis and antimalarial properties.

Authors:  A Brossi; B Venugopalan; L Dominguez Gerpe; H J Yeh; J L Flippen-Anderson; P Buchs; X D Luo; W Milhous; W Peters
Journal:  J Med Chem       Date:  1988-03       Impact factor: 7.446

9.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05

Review 10.  Qinghaosu (artemisinin): an antimalarial drug from China.

Authors:  D L Klayman
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

View more
  13 in total

1.  Artemisone uptake in Plasmodium falciparum-infected erythrocytes.

Authors:  Sophie Pooley; Farrah A Fatih; Sanjeev Krishna; Michael Gerisch; Richard K Haynes; Ho-Ning Wong; Henry M Staines
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

2.  First-in-humans study of the safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity.

Authors:  Shirin Bruderer; Noémie Hurst; Ruben de Kanter; Tommaso Miraval; Thomas Pfeifer; Yves Donazzolo; Jasper Dingemanse
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

Review 3.  Clinical pharmacology of artemisinin-based combination therapies.

Authors:  Polina I German; Francesca T Aweeka
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: A possible link.

Authors:  Gerald Geroldinger; Matthias Tonner; Judith Quirgst; Martin Walter; Sritama De Sarkar; Laura Machín; Lianet Monzote; Klaus Stolze; J Catharina Duvigneau; Katrin Staniek; Mitali Chatterjee; Lars Gille
Journal:  Biochem Pharmacol       Date:  2019-11-29       Impact factor: 5.858

5.  Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent.

Authors:  Carmony L Hartwig; Andrew S Rosenthal; John D'Angelo; Carol E Griffin; Gary H Posner; Roland A Cooper
Journal:  Biochem Pharmacol       Date:  2008-10-19       Impact factor: 5.858

6.  Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.

Authors:  Jutta Marfurt; Ferryanto Chalfein; Pak Prayoga; Frans Wabiser; Grennady Wirjanata; Boni Sebayang; Kim A Piera; Sergio Wittlin; Richard K Haynes; Jörg J Möhrle; Nicholas M Anstey; Enny Kenangalem; Ric N Price
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

7.  Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins.

Authors:  Delphine Cardi; Alexandre Pozza; Bertrand Arnou; Estelle Marchal; Johannes D Clausen; Jens Peter Andersen; Sanjeev Krishna; Jesper V Møller; Marc le Maire; Christine Jaxel
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

8.  Antimalarial Effects of Iranian Flora Artemisia sieberi on Plasmodium berghei In Vivo in Mice and Phytochemistry Analysis of Its Herbal Extracts.

Authors:  Hossein Nahrevanian; Bayram Sheykhkanlooye Milan; Masoud Kazemi; Reza Hajhosseini; Soudeh Soleymani Mashhadi; Shahab Nahrevanian
Journal:  Malar Res Treat       Date:  2012-01-23

9.  In Vivo Antimalarial Effects of Iranian Flora Artemisia khorassanica against Plasmodium berghei and Pharmacochemistry of its Natural Components.

Authors:  H Nahrevanian; B Esmaeili; M Kazemi; H Nazem; M Amini
Journal:  Iran J Parasitol       Date:  2010-03       Impact factor: 1.012

10.  Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.

Authors:  Joel Tarning; Frank Kloprogge; Patrice Piola; Mehul Dhorda; Sulaiman Muwanga; Eleanor Turyakira; Nitra Nuengchamnong; François Nosten; Nicholas P J Day; Nicholas J White; Philippe J Guerin; Niklas Lindegardh
Journal:  Malar J       Date:  2012-08-22       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.